Cape Investment Advisory, Inc. Charles River Laboratories International, Inc. Transaction History
Cape Investment Advisory, Inc.
- $256 Billion
- Q4 2024
A detailed history of Cape Investment Advisory, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cape Investment Advisory, Inc. holds 158 shares of CRL stock, worth $25,833. This represents 0.01% of its overall portfolio holdings.
Number of Shares
158
Previous 138
14.49%
Holding current value
$25,833
Previous $27.2 Million
7.3%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
710Shares Held
53.9MCall Options Held
122KPut Options Held
239K-
Vanguard Group Inc Valley Forge, PA6.16MShares$1.01 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$832 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.08MShares$666 Million0.14% of portfolio
-
State Street Corp Boston, MA2.18MShares$357 Million0.02% of portfolio
-
Allspring Global Investments Holdings, LLC1.81MShares$296 Million0.56% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $8.32B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...